StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a research report issued on Wednesday. The firm set a “buy” rating on the stock.
Mannatech Stock Up 2.9 %
Shares of MTEX stock opened at $12.40 on Wednesday. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.25 and a quick ratio of 0.74. Mannatech has a one year low of $6.75 and a one year high of $16.49. The company’s fifty day moving average price is $11.77 and its 200-day moving average price is $9.04. The company has a market capitalization of $23.30 million, a price-to-earnings ratio of -15.30 and a beta of 1.04.
Mannatech (NASDAQ:MTEX – Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter. The business had revenue of $31.73 million for the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Recommended Stories
- Five stocks we like better than Mannatech
- When to Sell a Stock for Profit or Loss
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- The Basics of Support and Resistance
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
